Information About Psychedelic Drugs for Addiction Care Providers

SUD Care Continuum ECHO®: Information About Psychedelic Drugs for Addiction Care Providers

As part of the twice-monthly SUD Care Continuum ECHO® series, Caroline Dorsen, PhD, FNP-BC, FAAN, will review the current evidence base, proposed mechanisms, and safety considerations for psychedelic substances in the treatment of mental health and substance use disorders and discuss a harm-reduction–informed framework to counsel patients about psychedelic use, including screening for risk, discussing potential benefits and harms, and addressing legal and ethical considerations in clinical practice. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.

Learn more and register

For trainings that indicate Continuing Education Units (CEUs) are available, contact your licensing or certification organization to verify that the credits will count toward the continuing education requirements.